Presentation: The impact of percent reduction in CA-125 levels on prediction of the extent of interval cytoreduction and outcome in patients with advanced stage cancer of müllerian origin treated with neoadjuvant chemotherapy (2015 Annual Meeting on Women's Cancer®)

Working to Eradicate Gynecologic Cancers

102
The impact of percent reduction in CA-125 levels on prediction of the extent of interval cytoreduction and outcome in patients with advanced stage cancer of müllerian origin treated with neoadjuvant chemotherapy

Sunday, March 29, 2015: 3:05 PM

Salon C-D (Hilton Chicago)

H. Mahdi, K. Maurer, B. Nutter and P. G. Rose
Cleveland Clinic, Cleveland, OH